Solvay fails to acquire more in Duphar

Belgian pharma group, Solvay Pharma’s move to acquire an additional 3.36 per cent stake in Duphar Pharma has run into a roadblock with the Foreign Investment Promotion Board (FIPB) deciding to consider the petitions from shareholders opposing the ...